293 Pill - white round, 10mm
Pill with imprint 293 is White, Round and has been identified as Metoprolol Succinate Extended-Release 25 mg. It is supplied by Ethex Corporation.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 293
Metoprolol Succinate Extended-Release
- Imprint
- 293
- Strength
- 25 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ethex Corporation
- National Drug Code (NDC)
- 58177-0293 (Discontinued)
- Inactive Ingredients
-
calcium stearate,
carboxymethylcellulose sodium,
carnauba wax,
croscarmellose sodium,
glyceryl behenate,
hypromelloses,
maltodextrin,
methacrylic acid - methyl methacrylate copolymer (1:1),
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
povidone,
sodium stearyl fumarate,
titanium dioxide,
triacetin,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "293"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (647)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Toprol-XL, Lopressor, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.